Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

CME

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

TAVR in Expanded Patient Populations: Exploring the Next Frontier

CME

TAVR in Expanded Patient Populations: Exploring the Next Frontier

TAVR in 2019: Appropriate Metrics for Success

CME

TAVR in 2019: Appropriate Metrics for Success

TAVR Evolves: Are You and the Heart Team Ready?

CME

TAVR Evolves: Are You and the Heart Team Ready?

TAVR and Imaging Modalities: Impact on Clinical Practice and Decision Making

CME

TAVR and Imaging Modalities: Impact on Clinical Practice and Decision Making

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

CME

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Recent TAVR Updates and Upcoming Studies at ACC 2016

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

CME

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Optimizing the TAVR Patient Pathway

CME

Optimizing the TAVR Patient Pathway

Optimizing the Duration of DAPT following PCI

CME

Optimizing the Duration of DAPT following PCI

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

New Clinical Data on TAVR use and Intermediate Risk Patients

Managing the Growing Epidemic of HF: The Potential Role of Shunts

CME

Managing the Growing Epidemic of HF: The Potential Role of Shunts

Low-Risk Patients: The Changing Face of TAVR

CME

Low-Risk Patients: The Changing Face of TAVR

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty & Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.